Table 1.
Patients’ general characteristics and information.
| Number of patients | 1695 |
|---|---|
| Age | Y |
| Mean (SD) | 57.2 (13.6) |
| Range | 19–88 |
| Gender | n (%) |
| Female | 1054 (62.2%) |
| Male | 641 (37.8%) |
| Indications | n (%) |
| Chemotherapy | 1197 (70.6%) |
| Difficult venous access | 248 (14.6%) |
| Parenteral nutrition | 174 (10.3%) |
| Some medications | 76 (4.5%) |
| Primary malignancy | N |
| Colorectal | 781 |
| Breast | 429 |
| Gastric | 127 |
| Pancreatic | 75 |
| Bladder | 63 |
| Lung | 57 |
| Prostate | 38 |
| Sarcoma MSK | 28 |
| Gallbladder | 24 |
| HCC | 20 |
| Testicular | 16 |
| Lymphoma | 12 |
| Esophageal | 6 |
| Ovarian | 5 |
| Small intestine | 5 |
| Kidney | 4 |
| Skin | 3 |
| Brain | 1 |
| Thymoma | 1 |
SD: standard deviation; HCC: hepatocellular carcinoma.